HIGH LEVELS OF CIRCULATING PLASMA CELLS ARE AN INDEPENDENT HIGH-RISK FEATURE IN MULTIPLE MYELOMA PATIENTS AND THEIR PROGNOSTIC IMPACT IS MODULATED BY THE ACHIEVEMENT OF MINIMAL RESIDUAL DISEASE NEGATIVITY

被引：0

作者：

Bertamini, L. ^{[1
]}

Stefanoni, P. ^{[1
]}

Tacchetti, P. ^{[1
]}

Ledda, A. ^{[1
]}

Palmas, A. ^{[1
]}

Gentile, M. ^{[1
]}

Palmieri, S. ^{[1
]}

Annibali, O. ^{[1
]}

Musolino, C. ^{[1
]}

Burdisso, M. ^{[1
]}

Capra, A. ^{[1
]}

Rizzi, R. ^{[1
]}

Molica, S. ^{[1
]}

Cellini, C. ^{[1
]}

Monaco, F. ^{[1
]}

De Sabbata, G. ^{[1
]}

Cea, M. ^{[1
]}

Rivolti, E. ^{[1
]}

Fazio, F. ^{[1
]}

Musto, P. ^{[1
]}

Boccadoro, M. ^{[1
]}

Gay, F. ^{[1
]}

机构：

[1] European Myeloma Network, Turin, Italy

来源：

HAEMATOLOGICA | 2021年 / 106卷 / 10期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

C008

引用

页码：12 / 13

页数：2

共 50 条

[31] High-risk myeloma and minimal residual disease postautologous-HSCT predict worse outcomes
Hu, Bei
Thall, Peter
Milton, Denai R.
Sasaki, Koji
Bashir, Qaiser
Shah, Nina
Patel, Krina
Popat, Uday
Hosing, Chitra
Nieto, Yago
Lin, Pei
Delgado, Ruby
Jorgensen, Jeffrey
Manasanch, Elisabet
Weber, Donna
Thomas, Sheeba
Orlowski, Robert Z.
Champlin, Richard
Qazilbash, Muzaffar H.
LEUKEMIA & LYMPHOMA, 2019, 60 (02) : 442 - 452
[32] High levels of peripheral blood circulating plasma cells as a specific risk factor for progression of smoldering multiple myeloma
Bianchi, G.
Kyle, R. A.
Larson, D. R.
Witzig, T. E.
Kumar, S.
Dispenzieri, A.
Morice, W. G.
Rajkumar, S. V.
LEUKEMIA, 2013, 27 (03) : 680 - 685
[33] High levels of peripheral blood circulating plasma cells as a specific risk factor for progression of smoldering multiple myeloma
G Bianchi
R A Kyle
D R Larson
T E Witzig
S Kumar
A Dispenzieri
W G Morice
S V Rajkumar
Leukemia, 2013, 27 : 680 - 685
[34] The use of minimal residual disease in patients with high-risk breast cancer.
Kameoka, Alyssa
Fukui, Jami Aya
JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
[35] Detection of minimal residual disease in high-risk neuroblastoma patients by digital PCR
Nishimura, Noriyuki
Ishida, Toshiaki
Uemura, Suguru
Yamamoto, Nobuyuki
Hasegawa, Daiichiro
CANCER SCIENCE, 2018, 109 : 1113 - 1113
[36] Prognostic Implications of Multiple Cytogenetic High-Risk Abnormalities in Patients with Newly Diagnosed Multiple Myeloma
Binder, Moritz
Rajkumar, S. Vincent
Ketterling, Rhett P.
Dispenzieri, Angela
Lacy, Martha Q.
Gertz, Morie A.
Buadi, Francis K.
Hayman, Suzanne R.
Hwa, Yi L.
Zeldenrust, Steven R.
Lust, John A.
Russell, Stephen J.
Leung, Nelson
Kapoor, Prashant
Go, Ronald S.
Gonsalves, Wilson I.
Kyle, Robert A.
Kumar, Shaji
BLOOD, 2016, 128 (22)
[37] PROGNOSTIC IMPLICATIONS OF MULTIPLE CYTOGENETIC HIGH-RISK ABNORMALITIES IN PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA
Binder, M.
Rajkumar, S. V.
Ketterling, R. P.
Dispenzieri, A.
Lacy, M. Q.
Gertz, M. A.
Buadi, F. K.
Hayman, S. R.
Hwa, Y. L.
Zeldenrust, S. R.
Lust, J. A.
Russell, S. J.
Leung, N.
Kapoor, P.
Go, R. S.
Gonsalves, W. I.
Kyle, R. A.
Kumar, S. K.
HAEMATOLOGICA, 2017, 102 : 107 - 107
[38] Clinical Feature and Predictive Model for Transplanted Patients with Functional High-Risk Multiple Myeloma
Yu, Tongyong
Li, Juan
BLOOD, 2024, 144 : 4727 - 4727
[39] Pure red cell aplasia and minimal residual disease conversion associated with immune reconstitution in a patient with high-risk multiple myeloma
Jin Xianghong
Jiang Xianyong
Wang Wei
Liu Shuangjiao
Han Bing
Han Jianhua
Zhuang Junling
慢性疾病与转化医学（英文）, 2023, 09 (04)
[40] STUDY OF THE CLINICAL RELEVANCE AND GENOMIC PROFILE OF MINIMAL RESIDUAL MULTIPLE MYELOMA DISEASE IN PATIENTS WITH STANDARD RISK AND HIGH CYTOGENETIC RISK
Goicoechea, I
Puig, N.
Cedena, M. T.
Cordon, L.
Vidriales, M. B.
Burgos, L.
Flores-Montero, J.
Gutierrez, N. C.
Calasanz, M. J.
Martin-Ramos, M. L.
Lara-Astiaso, D.
Botta, C.
Garcia-Sanz, R.
Martinez-Lopez, J.
Oriol, A.
Rios, R.
Martin, J.
Martinez, R.
Orfao, A.
Rosinol, L.
Mateos, M., V
Lahuerta, J. J.
Blade, J.
San-Miguel, J. F.
Paiva, B.
HAEMATOLOGICA, 2019, 104 : 5 - 5

← 1 2 3 4 5 →